BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2015 4:38:00 PM | Browse: 1140 | Download: 1589
 |
Received |
|
2014-07-06 14:01 |
|
Peer-Review Started |
|
2014-07-07 12:09 |
|
To Make the First Decision |
|
2014-08-06 17:16 |
|
Return for Revision |
|
2014-08-14 13:43 |
|
Revised |
|
2014-09-21 17:09 |
|
Second Decision |
|
2014-11-11 10:07 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2014-11-11 10:23 |
|
Articles in Press |
|
2014-11-11 10:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-02-03 16:53 |
|
Publish the Manuscript Online |
|
2015-02-11 16:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
María José Casanova, María Chaparro, Claudia Valenzuela, Carolina Cisneros and Javier P Gisbert |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| CIBEREHD is founded by Instituto de Salud Carlos III |
|
|
| Corresponding Author |
María José Casanova, MD, PhD, Gastroenterology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Canillas, 70 2º-G, CP 28002 Madrid, Spain. mjcasanova.g@gmail.com |
| Key Words |
Adalimumab; Anti-tumor necrosis factor; Crohn’s disease; Interstitial pneumonia |
| Core Tip |
Lung injury secondary to anti-tumor necrosis factor (TNF) drugs could cause severe respiratory symptoms in patients exposed to this therapy, and it should be suspected in patients who: have a temporal association between the onset of respiratory symptoms and the exposure to anti-TNF drugs, show a compatible pattern in the biopsy, and offer negative results for infection. There are a few cases reported of adalimumab-lung toxicity in patients with inflammatory bowel disease. Clinical improvement after biologic therapy discontinuation strongly supports the diagnosis. The mechanism by which anti-TNF drugs induce lung injury remains unclear; therefore, the use of another anti-TNF drug should be discouraged.
|
| Publish Date |
2015-02-11 16:38 |
| Citation |
Casanova MJ, Chaparro M, Valenzuela C, Cisneros C, Gisbert JP. Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease. World J Gastroenterol 2015; 21(7): 2260-2262 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i7/2260.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i7.2260 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
